⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

Official Title: A Phase Ⅲ Randomized Double-Blind Placebo-Controlled Study of Epoetin Beta for the Treatment of Chemotherapy-Induced Anemia (CIA) in Cancer Patients

Study ID: NCT00628043

Conditions

Anemia

Interventions

epoetin beta
placebo

Study Description

Brief Summary: This is a study to investigate the clinical efficacy and safety of epoetin beta 36,000 IU compared with placebo when administrated subcutaneously (s.c.) once-weekly for 12 weeks to anemic patients with lung cancer or gynecologic cancer undergoing chemotherapy.

Detailed Description:

Eligibility

Minimum Age: 20 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Chubu Region, Chubu, , Japan

Chugoku/Shikoku Region, Chugoku/Shikoku, , Japan

Hokkaido/Tohoku Region, Hokkaido/Tohoku, , Japan

Kanto/Koshinetsu Region, Kanto/Koshinetsu, , Japan

Kinki/Hokuriku Region, Kinki/Hokuriku, , Japan

Kyushu Region, Kyushu, , Japan

Contact Details

Name: Yoshito Suzuki

Affiliation: Chugai Pharmaceutical

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: